Sign Up to like & get
recommendations!
0
Published in 2017 at "Cancer letters"
DOI: 10.1016/j.canlet.2016.12.022
Abstract: HTLV-1 causes Adult T cell Leukemia/Lymphoma (ATLL) in humans. We describe an ATL-like disease in a 9 year-old female baboon naturally infected with STLV-1 (the simian counterpart of HTLV-1), with a lymphocyte count over 1010/L,…
read more here.
Keywords:
clonal complexity;
atll;
clonality;
stlv ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Modern Pathology"
DOI: 10.1038/s41379-020-0635-8
Abstract: Histopathological distinction between adult T-cell leukemia/lymphoma (ATLL) and other T-cell neoplasms is often challenging. The current gold standard for the accurate diagnosis of ATLL is the Southern blot hybridization (SBH) assay, which detects clonal integration…
read more here.
Keywords:
htlv;
cell leukemia;
atll;
diagnostic algorithm ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.am2024-3965
Abstract: Introduction: Adult T-cell leukemia/lymphoma (ATLL) is a rare blood cancer that develops in 3-5% of human T-lymphotropic virus-1 (HTLV1) carriers when the combination of viral oncoproteins and somatic mutations lead to malignant transformation of HTLV1…
read more here.
Keywords:
adult cell;
cd8;
response;
atll ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-4498
Abstract: Adult T-cell leukemia/lymphoma (ATLL), a rare form of non-Hodgkin lymphoma, affects approximately 2-5% of individuals infected by the retrovirus Human T-cell Lymphotropic Virus- 1 (HTLV-1). The disease has a dismal prognosis and resistance to chemotherapy…
read more here.
Keywords:
adult cell;
drug;
cell;
atll ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Case Reports in Oncology"
DOI: 10.1159/000525174
Abstract: Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic retrovirus. Of the approximate ten to twenty million people currently infected worldwide, 4–9% of infected individuals develop adult T-cell leukemia/lymphoma (ATLL) or HTLV-associated myelopathy/tropical spastic…
read more here.
Keywords:
lymphoma;
atll;
adult cell;
leukemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-117548
Abstract: Adult T-cell leukemia/lymphoma (ATLL) is highly aggressive CD4+ T cell malignancy caused by human T-cell leukemia virus type 1 (HTLV-1). Normal cellular counterpart of ATLL is considered to be CD4+Foxp3+ regulatory T cells (Tregs) and…
read more here.
Keywords:
treg;
ccr4;
treatment;
atll ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-140630
Abstract: INTRODUCTION: Adult T-cell leukemia/lymphoma (ATLL) is a mature peripheral T-cell neoplasm caused by the Human T-cell Leukemia Virus Type 1 (HTLV-1). HTLV-1 infects up to 10 million people worldwide and is most endemic in Southwestern…
read more here.
Keywords:
atll;
epidemiology;
speakers bureau;
research funding ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-206160
Abstract: Background: North American ATLL (NA-ATLL) is a highly aggressive HTLV-I-associated T-cell malignancy with a dismal prognosis. Venetoclax has shown activity in other T-cell malignancies, alone or in combination with hypomethylating agents (HMA), AZT (Zidovudine) with…
read more here.
Keywords:
combination;
atll cell;
cell;
atll ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Blood"
DOI: 10.1182/blood.2019001815
Abstract: Adult T-cell leukemia/lymphoma (ATLL) in Japan presents at a median age of 70 and only 5% of patients are age
read more here.
Keywords:
landscape young;
cd28 fusions;
atll;
genomic landscape ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e18603
Abstract: e18603 Background: Adult T-cell leukemia/lymphoma (ATLL), a malignancy of CD4+ T-cells linked to HTLV-1 infection, carries a poor prognosis. Treatment options beyond allogeneic transplantation remain limited. Mogamulizumab, a CCR4-targeting monoclonal antibody, is FDA-approved for relapsed…
read more here.
Keywords:
treatment;
cohort;
real world;
atll ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "PLoS Neglected Tropical Diseases"
DOI: 10.1371/journal.pntd.0010807
Abstract: Background Adult T-cell leukemia/lymphoma (ATLL), a peripheral T-cell leukemia/lymphoma associated with the human T-cell lymphotropic virus type-1 (HTLV-1), has been classified following the clinical forms defined by Shimoyama in 1991. A suggestion to modify Shimoyama’s…
read more here.
Keywords:
cell;
prognosis;
atll;
leukemia lymphoma ... See more keywords